Shares of clinical-stage biotech firm Sangamo Therapeutics Inc. fell nearly 3% in Monday's after-hours trading following ...

Sangamo Therapeutics Inc (NASDAQ:SGMO) shares are surging in Thursday’s after-hours session after the company announced a new agreement with pharmaceutical giant Eli Lilly And Co (NYSE: LLY). What ...

SANGAMO THERAPEUTICS ($SGMO) is expected to release its quarterly earnings data on Monday, March 17th after market close, per Finnhub. Analysts are expecting revenue ...

RICHMOND, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the pricing of an underwritten offering consisting of 12,235,000 shares of ...

Sangamo Therapeutics (SGMO) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago. These ...

RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it has entered into a securities purchase agreement with institutional ...

Sangamo Therapeutics (NASDAQ:SGMO – Free Report) had its price objective lowered by Barclays from $9.00 to $5.00 in a research report released on Wednesday morning,Benzinga reports. Barclays currently ...

Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & ...

Sangamo Therapeutics Inc. (NASDAQ:SGMO) is one of the best penny stocks under $1 to buy now. On June 24, Sangamo Therapeutics announced positive topline results from its registrational Phase 1/2 STAAR ...